natgillin/translations-raw huggingface dataset:
Patients started on CSII must receive comprehensive instruction in the use of the pump, and the necessary actions in case of illness, hypoglycaemia, hyperglycaemia or pump failure. 
Bolniki, ki za enjajo zdravljenje s stalno subkutano infuzijo insulina, morajo dobiti iz rpna navodila o uporabi rpalke in potrebnem ukrepanju v primeru bolezni, hipoglikemije, hiperglikemije ali odpovedi rpalke.
Velosulin is administered subcutaneously in the abdominal wall. 
Velosulin se subkutano injicira v trebušno steno.
Intensified control in the treatment of pregnant women with diabetes is therefore recommended throughout pregnancy and when contemplating pregnancy. 
Zato je pri ženskah z diabetesom med nose nostjo in kadar želijo zanositi priporo ljivo intenzivnejše nadziranje.
It is supplied in packs of 1 or 5 vials of 10 ml or in a multipack of 5 x (1 x 10 ml) vials. 
Opremljena v pakiranjih z 1 ali 5 10-ml vialami ali v pakiranjih z ve vialami, v katerih je 5 x (1 x 10 ml) vial (na trgu lahko ni vseh navedenih pakiranj).
Discuss with your doctor whether you can drive or use machines at all, if you have a lot of hypos or if you find it hard to recognise hypos. 
Nikdar ne vozite in ne uporabljajte strojev, e utite, da se pojavlja hipa.Z zdravnikom se posvetujte, ali lahko sploh vozite ali upravljate s stroji, e doživljate veliko hip ali hipe težko prepoznate.
Use in syringes 
Uporaba v brizgah
They include: increased urination; feeling thirsty; losing your appetite; feeling sick (nausea or vomiting); feeling drowsy or tired; flushed, dry skin; dry mouth and a fruity (acetone) smell of the breath. 
Med njimi so: pove ano uriniranje, ob utek žeje, izguba apetita, ob utek slabosti (slabost ali bruhanje), ob utek zaspanosti ali utrujenosti, pordela, suha koža, suha usta in zadah z vonjem po sadju (acetonu).
Medicinal products added to the insulin solution may cause degradation of the insulin, e.g. if the medicinal products contain thiols or sulphites. 
Insulinska zdravila je dovoljeno dodajati le snovem, s katerimi so znano kompatibilna.Zdravila, dodana raztopini insulina, lahko povzro ijo razgradnjo insulina, npr. e zdravilo vsebuje tiole ali sulfite.
Always have ordinary syringes available in case of pump interruption or failure. 
Vedno imejte na zalogi navadne brizge za primer, da rpalka preneha delovati ali odpove.
Monitoring of the patient's blood glucose during infusion is therefore recommended. 
Med infundiranjem je zato priporo ljivo nadziranje bolnikove glukoze v krvi.
4.6 Pregnancy and lactation 
4.6 Nose nost in dojenje
MARKETING AUTHORISATION NUMBERS EU/1/02/232/001 1 x 10 ml 
ŠTEVILKA(E) DOVOLJENJA (DOVOLJENJ) ZA PROMET EU/1/02/232/001 1 x 10 ml
If your blood glucose levels improve very fast it may cause a burning, tingling or electric pain. 
e se vam koncentracija sladkorja v krvi izboljša zelo hitro, lahko to povzro i peko ob utek, mravljin enje ali elektri ne bole ine.
Velosulin vials are for use with insulin syringes with the corresponding unit scale. 
Viale zdravila Velosulin so namenjene uporabi z insulinskimi brizgami, ki imajo ustrezno odmerno skalo.
Refraction anomalies may occur upon initiation of insulin therapy. 
Po za etku zdravljenja z insulinom se lahko pojavijo refrakcijske anomalije.
Dosage 
Presnova
zinc chloride, glycerol, metacresol, disodium phosphate dihydrate, sodium hydroxide, hydrochloric acid and water for injections. 
cinkov klorid, glicerol, metakrezol, natrijev hidrogenfosfat dihidrat, natrijev hidroksid, klorovodikova kislina in voda za injekcije.
Patients administering Velosulin by CSII must have injection syringes and alternative insulin readily available in case of emergency or pump interruption or failure, in order that insulin can be administered by subcutaneous injection. 
Bolniki, ki Velosulin uporabljajo v stalni subkutani infuziji, morajo imeti pri roki brizge in drug insulin, e se zgodi, da rpalka preneha delovati ali odpove; tako si lahko insulin aplicirajo s subkutano injekcijo.
When administered by CSII no other medicinal products or other insulin products should be mixed in the reservoir of the infusion pump with Velosulin. 
Kadar se Velosulin uporablja v stalni subkutani infuziji, se z njim v rezervoarju infuzijske rpalke ne sme mešati nobenih drugih zdravil ali drugih insulinov.
Disodium phosphate dihydrate Sodium hydroxide (for pH adjustment) Hydrochloric acid (for pH adjustment) Water for injections 
6.1 Seznam pomožnih snovi cinkov klorid glicerol metakrezol natrijev hidrogenfosfat dihidrat natrijev hidroksid (za uravnavo pH) klorovodikova kislina (za uravnavo pH) voda za injekcije
Omission of a meal or unplanned, strenuous physical exercise may lead to hypoglycaemia. 
Izpustitev obroka ali nena rtovana, naporna telesna dejavnost lahko povzro ita hipoglikemijo.
The vials may be used with insulin syringes with a corresponding unit scale. 
Viale so namenjene uporabi z insulinskimi brizgami, ki imajo ustrezno odmerno skalo.
See also warning in 2 Before you use Velosulin. 
Kaj morate vedeti, preden boste uporabili Velosulin.
STATEMENT OF ACTIVE SUBSTANCE 1 ml solution contains 100 IU (3.5 mg) of insulin human (rDNA). 
NAVEDBA ENE ALI VE ZDRAVILNIH U INKOVIN 1 ml raztopine vsebuje 100 i.e. (3,5 mg) humanega insulina (rDNA),
Oral contraceptives, thiazides, glucocorticoids, thyroid hormones and beta-sympathomimetics, growth hormone and danazol. 
Potrebo po insulinu lahko zve ajo naslednje snovi: peroralni kontraceptivi, tiazidi, glukokortikoidi, š itni ni hormoni, beta-simpatikomimetiki, rastni hormon in danazol.
- The other ingredients are zinc chloride, glycerol, metacresol, disodium phosphate dihydrate, sodium hydroxide, hydrochloric acid and water for injections. 
- Pomožne snovi so cinkov klorid, glicerol, metakrezol, dinatrijev fosfat dihidrat, natrijev hidroksid, klorovodikova kislina in voda za injekcije.
MARKETING AUTHORISATION NUMBER(S) EU/1/02/232/003 
ŠTEVILKA(E) DOVOLJENJA (DOVOLJENJ) ZA PROMET EU/1/02/232/003
MARKETING AUTHORISATION NUMBER(S) EU/1/02/232/001-003 
ŠTEVILKA(E) DOVOLJENJA(DOVOLJENJ) ZA PROMET EU/1/02/232/001-003
Always keep the vial in the outer carton when you're not using it in order to protect it from light. 
Kadar viale ne uporabljate, jo vedno shranjujte v zunanji ovojnini, da bo zaš itena pred svetlobo.
Close blood glucose monitoring is therefore recommended. 
Zato je priporoljivo natanno nadzorovanje glukoze v krvi.
Draw air into the syringe, in the same amount as the dose of insulin you need Inject the air into the vial: push the needle through the rubber stopper and press the plunger Turn the vial and syringe upside down 
Injicirajte zrak v vialo: potisnite iglo skozi gumijasti zamašek in pritisnite bat.
You get a hypo if your blood sugar gets too low. 
Hipa se pojavi, e se sladkor v krvi preve zniža.
Don't take any insulin if you feel a hypo coming on. 
e utite, da se pojavlja hipa, si ne dajajte insulina.
6 HOW TO STORE VELOSULIN 
SHRANJEVANJE ZDRAVILA VELOSULIN
Follow the instructions of your doctor or diabetes nurse concerning the correct mixing procedure. 
Za mešanje zdravila Velosulin z dolgodelujo im insulinom Upoštevajte navodila, ki ste jih za pravilen postopek mešanja dobili od zdravnika ali diabetološke sestre.
Usual warning symptoms may disappear in patients with longstanding diabetes. 
Pri bolnikih, ki imajo diabetes že dolgo, lahko obi ajni opozorilni simptomi izginejo.
Velosulin should never be mixed with any other insulin when used in a pump. 
e se Velosulin uporablja v rpalki, se ga nikoli ne sme mešati z nobenim drugim insulinom.
Insulin infusion (CSII): 
Infundiranje insulina (stalna subkutana infuzija insulina):
SPECIAL WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT 
POSEBNO OPOZORILO O SHRANJEVANJU ZDRAVILA ZUNAJ DOSEGA IN Zdravilo shranjujte nedosegljivo otrokom!
Carry glucose tablets, sweets, biscuits or fruit juice with you, just in case. 
Za vsak primer vedno imejte pri sebi tablete glukoze, bonbone, piškote ali sadni sok.
Keep the vial in the outer carton in order to protect from light. 
Vialo shranjujte v zunanji ovojnini za zaš ito pred svetlobo!
If they do not disappear, see your doctor. 
e ne minejo, pojdite k zdravniku.
MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS VIAL LABEL 
ŠKATLAPODATKI, KI MORAJO BITI NAJMANJ NAVEDENI NA MANJŠIH STI NIH
PARTICULARS TO APPEAR ON THE OUTER PACKAGING AND THE IMMEDIATE PACKAGING 
Izgled zdravila Velosulin in vsebina pakiranja
• If you take too much insulin 
• uporabite preve insulina,
NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION Velosulin 100 IU/ml solution for injection or infusion Insulin human (rDNA) 
IME ZDRAVILA IN POT(I) UPORABE Velosulin 100 i.e./ml raztopina za injiciranje ali infundiranje humani insulin (rDNA)
Follow their advice carefully. 
Natan no upoštevajte njihova navodila.
What Velosulin looks like and contents of the pack The solution for injection or infusion comes as a clear, colourless, aqueous solution. 
Raztopina za injiciranje ali infundiranje je bistra, brezbarvna, vodna raztopina.
Velosulin 100 IU/ml solution for injection in a vial Insulin human (rDNA) 
Velosulin 100 i.e./ml raztopina za injiciranje v viali humani insulin (rDNA)
If you notice your skin pitting or thickening at the injection site, tell your doctor or diabetes nurse because these reactions can become more severe, or they may change the absorption of your insulin if you inject in such a site. 
Takšne reakcije namre lahko postanejo hujše ali spremenijo absorpcijo insulina, e ga injicirate na takšno mesto.
Injection site reactions (redness, swelling, itching, pain and haematoma at the injection site) may occur during treatment with insulin. 
Med zdravljenjem z insulinom se lahko pojavijo reakcije na injekcijskem mestu (pordelost, oteklost, srbenje, bole ine in hematomi na injekcijskem mestu).
Ask your pharmacist how to dispose of medicines no longer required. 
O na inu odstranjevanja zdravila, ki ga ne potrebujete ve, se posvetujte s farmacevtom.
EFFECTIVE USE OF THE MEDICINAL PRODUCT Not applicable. 
Navedba smiselno ni potrebna.
OUTER CARTON 
Izlo anje
Store in a refrigerator (2°C - 8°C) Do not freeze 
Shranjujte v hladilniku (med 2 °C in 8 °C)!
Injection into a lifted skin fold minimises the risk of unintended intramuscular injection. 
Injiciranje v dvignjeno kožno gubo minimizira tveganje za nenamerno intramuskularno injiciranje.Igla mora ostati pod kožo vsaj 6 sekund, da je zagotovljeno injiciranje celotnega odmerka.
Swollen joints. 
Otekli sklepi.
If you have trouble with your kidneys or liver, or with your adrenal, pituitary or thyroid glands If you are drinking alcohol: watch for signs of a hypo and never drink alcohol on an empty 
Pri uporabi zdravila Velosulin bodite posebej pozorni, e imate težave z ledvicami, jetri, nadledvi no žlezo, hipofizo ali š itnico; pijete alkohol: pazite na znake hipe in alkohola nikdar ne pijte na prazen želodec; ste telesno bolj dejavni kot ponavadi ali želite spremeniti svojo obi ajno prehrano; ste bolni: insulin uporabljajte še naprej; potujete v tujino: potovanje med razli nimi asovnimi pasovi lahko vpliva na potrebe po
Keep the vial in the outer carton in order to protect from light During use: do not refrigerate or store above 25°C May be kept in an infusion pump at up to 37°C for 6 days 
Med uporabo: ne shranjujte v hladilniku; hranite pri temperaturi do 25 °C.
See 4 What to do in an emergency for more about hypos. 
Za podrobnosti o hipah glejte poglavje 4.
Your ability to concentrate or to react will be less during a hypo. Never drive or use machinery if you feel a hypo coming on. 
Vaša sposobnost za koncentracijo ali reagiranje se med hipo zmanjša.
POSSIBLE SIDE EFFECTS 
Možni neželeni uinki).
EXP/ 
do/
Subcutaneous or intravenous use Read the package leaflet before use 
Pred uporabo natan no preberite priloženo navodilo!
NAME OF THE MEDICINAL PRODUCT Velosulin 100 IU/ml solution for injection or infusion in a vial Insulin human (rDNA) 
Velosulin 100 i.e./ml raztopina za injiciranje ali infundiranje v viali humani insulin (rDNA)
Draw the right dose of insulin into the syringe Pull the needle out of the vial 
Potegnite v brizgo pravi odmerek insulina.
GENERAL CLASSIFICATION FOR SUPPLY Medicinal product subject to medical prescription 
Imetnik dovoljenja za promet z zdravilom in izdelovalec
Marketing Authorisation Holder and Manufacturer Novo Nordisk A/S 
Novo Nordisk A/S Novo Nordisk A/S Novo Allé
If severe hypoglycaemia is not treated, it can cause brain damage (temporary or permanent) 
Nezdravljena huda hipoglikemija lahko povzro i (prehodno ali trajno) okvaro možganov in e doživite hipo, zaradi katere se onesvestite, ali doživljate veliko hip, se posvetujte z zdravnikom.
Oedema may occur upon initiation of insulin therapy. 
Ob asni- edemi Po za etku zdravljenja z insulinom se lahko pojavijo edemi.
Upon regaining consciousness, administration of oral carbohydrate is recommended for the 
Ko se bolnik zave, je priporo ljivo, da peroralno dobi ogljikove hidrate za prepre itev ponovitve.
NAME OF THE MEDICINAL PRODUCT Velosulin 100 IU/ml solution for injection or infusion in a vial. 
Velosulin 100 i.e./ml raztopina za injiciranje ali infundiranje v viali
Frequencies of adverse drug reactions from clinical trials that are considered related to fast-acting ≥1/1,000 to human insulin (Actrapid) are listed below. 
Spodaj so navedene pogostnosti neželenih reakcij nastalih v klini nih preskušanjih, ki so po splošni presoji povezane z zdravilom Velosulin.
- If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, 
- e kateri koli neželeni u inek postane resen ali e opazite katerikoli neželeni u inek, ki ni omenjen v tem navodilu, obvestite svojega zdravnika, diabetološko sestro ali farmacevta.
Patients should be closely monitored throughout this period. 
Bolnike je treba ves ta čas skrbno nadzorovati.
EXP Use within 3 months after first opening. 
EXP: Uporabite v 3 mesecih po prvem odprtju.
Currently available data are described in section 5.1 but no recommendation on a posology can be made. 
Trenutno razpoložljivi podatki so opisani v poglavju 5.1, vendar pa priporočil o odmerjanju ni mogoče podati.
DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION Date of first authorisation: 20 August 2015 
Datum prve odobritve: 20. avgust 2015
Consequently, the frequency of these adverse events is qualified as "not known" 
Zato je pogostnost teh neželenih učinkov opredeljena kot »neznana«.
There are a further 154 cumulative spontaneous reports of eye movement disorder, of which 22 were serious. 
Obstaja še skupaj 154 spontanih poročil o motnjah gibanja oči, od katerih je bilo 22 resnih.
1407 Sofia, Bulgaria Teл. 
1407 Sofia, BulgariaTeл.
Use within 3 months after first opening of the bottle. 
Uporabite v 3 mesecih po prvem odprtju plastenke.
Str. Livezeni nr. 7A Târgu Mureş 540472 Romania 
Str. Livezeni nr. 7A Târgu Mureş 540472 Romunija
indinavir, ritonavir) 
npr. indinavir, ritonavir),
Moreover there is also some evidence based on scientific literature that the use of antipsychotics (even second generation antipsychotics like aripiprazole) is associated with an increase in the risk of falls and fractures, especially among the older population. 
Poleg tega obstajajo nekateri dokazi, ki temeljijo na znanstveni literaturi, da je uporaba antipsihotikov (celo druga generacija antipsihotikov, kot je aripiprazol) povezana s povečanim tveganjem za pojav padcev in zlomov, zlasti med starejšo populacijo.
If you are an elderly patient suffering from dementia (loss of memory and other mental abilities), you or your carer/relative should tell your doctor if you have ever had a stroke or "mini" stroke. 
Če ste starejši bolnik in imate demenco (slabšanje spomina in drugih duševnih sposobnosti), morate vi ali vaš skrbnik/sorodnik zdravniku povedati, če ste kdaj imeli možgansko kap ali "malo" kap.
Less than 1% of unchanged aripiprazole was excreted in the urine and approximately 18% was recovered unchanged in the faeces. 
Manj kot 1 % aripiprazola se je nespremenjenega izločilo v urin in približno 18 % ga je bilo mogoče nespremenjenega najti v blatu.
This leaflet was last revised in {MM/YYYY}. 
Navodilo je bilo nazadnje revidirano dne <{MM/LLLL}
[Only Carton for bottle:] PC: {number} SN: {number} NN: {number} 
[Samo za zunanjo ovojnino plastenke:] PC: {številka}
Try to take Aripiprazole Sandoz at the same time each day. 
Prizadevajte si vzeti zdravilo Aripiprazol Sandoz vsak dan ob istem času.
Do not take Aripiprazole Sandoz • if you are allergic to aripiprazole or any of the other ingredients of this medicine (listed in section 6). 
Ne jemljite zdravila Aripiprazol Sandoz če ste alergični na aripiprazol ali katero koli sestavino tega zdravila (navedeno v poglavju 6).
During antipsychotic treatment, improvement in the patient's clinical condition may take several days to some weeks. 
Med antipsihotičnim zdravljenjem lahko do izboljšanja bolnikovega kliničnega stanja mine od nekaj dni do nekaj tednov.
The requirements for submission of periodic safety update reports for this medicinal product are set out in the list of Union reference dates (EURD list) provided for under Article 107c(7) of Directive 2001/83/EC and any subsequent updates published on the European medicines web-portal. 
• Redno posodobljena poročila o varnosti zdravila (PSUR) Zahteve za predložitev redno posodobljenih poročil o varnosti zdravila za to zdravilo so določene v seznamu referenčnih datumov Unije (seznamu EURD), opredeljenem v členu 107c(7) Direktive 2001/83/ES in objavljenem na evropskem spletnem portalu o zdravilih.
Doses higher than 10 mg/day should therefore only be used in exceptional cases and with close clinical monitoring (see sections 4.4, 4.8 and 5.1). 
Odmerke, večje od 10 mg/dan je zato treba uporabiti le v izjemnih primerih in ob skrbnem kliničnem nadzoru (glejte poglavja 4.4, 4.8 in 5.1).
If you forget to take Aripiprazole Sandoz If you miss a dose, take the missed dose as soon as you remember but do not take two doses in one day. 
Če ste pozabili vzeti zdravilo Aripiprazol Sandoz Če ste pozabili vzeti odmerek, ga vzemite takoj, ko se spomnite, vendar ne vzemite dveh odmerkov na en dan.
Schizophrenia in adolescents aged 15 years and older 
Shizofrenija pri mladostnikih, starih 15 let in več
Sandoz GmbH Biochemiestrasse 10 6250 Kundl Austria 
Sandoz GmbH Biochemiestrasse 10 6250 Kundl Avstrija
Aripiprazole Sandoz with food, drink and alcohol This medicine can be taken regardless of meals. 
Zdravilo Aripiprazol Sandoz skupaj s hrano, pijačo in alkoholom To zdravilo lahko jemljete ne glede na obroke.
The table is based on adverse events reported during clinical trials and/or post-marketing use. 
Preglednica temelji na neželenih učinkih, o katerih so poročali med kliničnimi preskušanji in/ali med uporabo v obdobju trženja.
Blood pressure-lowering medicines: Aripiprazole Sandoz may increase the effect of medicines used to lower the blood pressure. 
Zdravila za zniževanje krvnega tlaka: zdravilo Aripiprazol Sandoz lahko okrepi učinek zdravil, ki se uporabljajo za zniževanje krvnega tlaka.
Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system listed in Appendix V. 
Od zdravstvenih delavcev se zahteva, da poročajo o katerem koli domnevnem neželenem učinku zdravila na: nacionalni center za poročanje, ki je naveden v Prilogi V.
Even if you feel better, do not alter or discontinue the daily dose of Aripiprazole Sandoz without first consulting your doctor. 
Tudi če se počutite bolje, ne spreminjajte dnevnega odmerka in ne nehajte jemati zdravila Aripiprazol Sandoz, ne da bi se prej posvetovali z zdravnikom.
Risk factors that may predispose patients to severe complications include obesity and family history of diabetes. 
Med dejavniki tveganja, ki lahko povečajo bolnikovo nagnjenost k hudim zapletom, sta debelost in družinska anamneza sladkorne bolezni.
At therapeutic concentrations, aripiprazole and dehydroaripiprazole are greater than 99% bound to serum proteins, binding primarily to albumin. 
V terapevtskih koncentracijah je več kot 99 % aripiprazola in dehidroaripiprazola vezanega na beljakovine v serumu, predvsem na albumin.
Based on results of a full range of standard genotoxicity tests, aripiprazole was considered non-genotoxic. 
Na podlagi celotnega spektra standardnih preskusov genotoksičnosti je bilo ocenjeno, da aripiprazol ni genotoksičen.
LIST OF EXCIPIENTS Also contains: lactose monohydrate. 
SEZNAM POMOŽNIH SNOVI Vsebuje tudi: laktoza monohidrat.
Urinary incontinence Urinary retention 
Bolezni sečil urinska inkontinenca retenca urina
The point estimate of the hazard ratio (HR) was 0.461 (95% confidence interval, 0.242-0.879) in the full population. 
Ocenjena vrednost razmerja ogroženosti (RO) je bila 0,461 (95% interval zaupanja, 0,242-0,879) pri celotni poulaciji.
If you have the impression that the effect of Aripiprazole Sandozis too strong or too weak, talk to your doctor or pharmacist. 
Če menite, da je učinek zdravila Aripiprazol Sandoz premočan ali prešibak, se posvetujte z zdravnikom ali farmacevtom.
Prolactin levels were evaluated in all trials of all doses of aripiprazole (n=28,242). 
V vseh preizkušanjih z vsemi odmerki aripiprazola so ocenili ravni prolaktina (n = 28.242).
However, the estimation of the HR for the younger (13-14 years) group was not precise, reflecting the smaller number of subjects in that group (aripiprazole, n = 29; placebo, n = 12), and the confidence interval for this estimation (ranging from 0.151 to 1.628) did not allow conclusions to be drawn on the presence of a treatment effect. 
Vendar pa ocena RO pri skupini mlajših mladostnikov (13-14 let) ni bila točna zaradi manjšega števila udeležencev v tej skupini (aripiprazol, n = 29; placebo, n = 12), interval zaupanja za to oceno (ki je od 0,151 do 1,628) pa ne omogoča zaključkov o prisotnosti učinka zdravljenja.
Aluminium//Aluminium blister. 
Pretisni omot aluminij/aluminij.
Caution should be taken when treating patients at higher risk, and a lower starting dose should be considered (e.g elderly or debilitated patients) (see section 4.2). 
Pri zdravljenju bolnikov z večjim tveganjem je potrebna previdnost, zato je treba razmisliti o nižjem začetnem odmerku (npr. pri starejših ali oslabljenih bolnikih; glejte poglavje 4.2).
If you take more Aripiprazole Sandoz than you should If you realise you have taken more Aripiprazole Sandoz than your doctor has recommended (or if someone else has taken some of your Aripiprazole Sandoz), contact your doctor right away. 
Če ste vzeli večji odmerek zdravila Aripiprazol Sandoz, kot bi smeli Če ugotovite, da ste vzeli več zdravila Aripiprazol Sandoz, kot vam je priporočil zdravnik (ali če je vaše zdravilo Aripiprazol Sandoz vzel kdo drug), se takoj posvetujte s svojim zdravnikom.
Aripiprazole Sandoz is effective in a dose range of 10 to 30 mg/day. 
Zdravilo Aripiprazol Sandoz je učinkovito v razponu odmerkov od 10 do 30 mg/dan.
The European Medicines Agency has deferred the obligation to submit the results of studies with the reference medicinal product containing aripiprazole in one or more subsets of the paediatric population in the treatment of schizophrenia and in the treatment of bipolar affective disorder (see section 4.2 for information on paediatric use). 
Evropska agencija za zdravila je začasno odložila zahtevo za predložitev rezultatov študij z zdravilom Aripiprazol Sandoz za eno ali več podskupin pediatrične populacije pri zdravljenju shizofrenije in bipolarne afektivne motnje (za podatke o uporabi pri pediatrični populaciji glejte poglavje 4.2).
stroke or "mini" stroke, abnormal blood pressure 
"malo" kap, nenormalen krvni tlak,
HDPE bottle containing a silica gel desiccant and a polyester coil packed in cartons containing 100 tablets. 
Plastenka HDPE, ki vsebuje silikagelno sušilno sredstvo in poliestrski navoj, pakirana v škatlo, ki vsebuje 100 tablet.
In subgroup analyses the point estimate of the HR was 0.495 for subjects 13 to 14 years of age compared to 0.454 for subjects 15 to 17 years of age. 
Pri analizi podskupin je bila ocenjena vrednost RO pri udeležencih, starih od 13 do 14 let, 0,495 v primerjavi z udeleženci, starimi od 15 do 17 let, pri katerih je razmerje bilo 0,454.